Transpek Industry Limited Q4 FY26 results deck summary

Results deck of 12 Jun 2026, summarised by AI from the filing.

FY26 revenue ₹645.7 cr (FY25: ₹678.6 cr, -4.8%) on subdued demand; a few products expected to commercialize in 2026-2027.

Key takeaways

1. FY26 revenue FY26 total revenue from operations ₹645.7 cr (FY25: ₹678.6 cr, -4.8%), impacted by subdued demand and weaker western markets.
2. Product commercialization A few products in advanced stage of development are expected to commercialize in 2026-2027.
3. Q4 margin Q4 FY26 EBITDA margin fell to 14.4% from 23.1% in Q4 FY25, with EBITDA at ₹22.0 cr.
4. Product mix FY26 saw higher contribution from organic peroxides, agrochemicals, dyes and surfactants, reflecting the diversified portfolio.
5. Demand risk Management remains cautious amid uncertainty surrounding the West Asia conflict and its potential impact on global demand and supply.

Original filing on BSE

Transpek Industry Limited earnings call, investor presentation and press release summaries

• Q1 FY27: Earnings call (20 Aug 2026), Results deck (19 Aug 2026)
• Q4 FY26: Results deck (12 Jun 2026)
• Q3 FY26: Results deck (18 Feb 2026)
• Q2 FY26: Results deck (24 Nov 2025)
• Q1 FY26: Results deck (29 Aug 2025)
• Q4 FY25: Results deck (16 May 2025)